Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Digestive system diseases
MeSH D004066 - digestive system diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004066:
Digestive system diseases
1 Company
1 Drug
$
Success rate
D001660:
Biliary tract diseases
0 Companies
0 Drugs
Success rate
D004065:
Digestive system abnormalities
0 Companies
0 Drugs
Success rate
D004067:
Digestive system neoplasms
0 Companies
0 Drugs
Success rate
D005767:
Gastrointestinal diseases
32 Companies
12 Drugs
$
Success rate
D008107:
Liver diseases
2 Companies
2 Drugs
$
Success rate
D010182:
Pancreatic diseases
0 Companies
0 Drugs
Success rate
D010532:
Peritoneal diseases
0 Companies
0 Drugs
Success rate
D016154:
Digestive system fistula
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
73
%
8/11
Phase 2
35
%
6/17
Phase 3
17
%
2/12
Approved:
2
Overall Success rate:
4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Qol Medical
Sacrosidase
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use